Results 81 to 90 of about 1,932 (130)

[Evaluation of Implementation of the HEARTS Initiative in a Rural Community in Venezuela, 2023Avaliação da implementação da iniciativa HEARTS em uma comunidade rural da Venezuela, 2023]. [PDF]

open access: yesRev Panam Salud Publica
Durán M   +10 more
europepmc   +1 more source

Brazilian Cardio-oncology Guideline - 2020. [PDF]

open access: yesArq Bras Cardiol, 2020
Hajjar LA   +54 more
europepmc   +1 more source

The potential contribution of ranolazine to Torsade de Pointe. [PDF]

open access: yesJ Cardiovasc Dis Res, 2013
Liu Z, Williams RB, Rosen BD.
europepmc   +1 more source

Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease - 2020. [PDF]

open access: yesArq Bras Cardiol, 2020
Avila WS   +33 more
europepmc   +1 more source

Out-of-pocket pharmaceutical expenditure and potential misuse of public resources - analysis in the Italian context. [PDF]

open access: yesCost Eff Resour Alloc
Maurmo L   +8 more
europepmc   +1 more source

Influence of type 2 diabetes on symbolic analysis and complexity of heart rate variability in men. [PDF]

open access: yesDiabetol Metab Syndr, 2014
Moura-Tonello SC   +9 more
europepmc   +1 more source

Comparación de la combinación hidroclorotiazida/bisoprolol con enalapril/amlodipina en el manejo de la hipertensión arterial no controlada

open access: yes, 2008
La hipertensión arterial afecta aproximadamente 50 millones de individuos en Estados Unidos de América y un mil millones de individuos en el resto del mundo, afectando de un 15 % a 30 % de la población mundial, y es uno de los factores predictivos de enfermedad cardiovascular más importantes, por lo tanto su control es indispensable.
Fuenmayor, Pedro José   +1 more
openaire   +1 more source

Mind the gap in kidney care: translating what we know into what we do. [PDF]

open access: yesJ Bras Nefrol
Luyckx VA   +18 more
europepmc   +1 more source

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial. [PDF]

open access: yesFront Pharmacol, 2018
Buonerba C   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy